Bluejay Diagnostics (BJDX) Share-based Compensation (2020 - 2025)
Bluejay Diagnostics recorded quarterly Share-based Compensation of $74.0 in Q4 2025, down 59.56% quarter-over-quarter from $183.0 in Q3 2025, and up 102.87% year-over-year from $36.48 in Q4 2024.
Bluejay Diagnostics' Share-based Compensation history runs 6 years deep, the most recent figure standing at $74.0 for Q4 2025.
- In Q4 2025, Share-based Compensation rose 102.87% year-over-year to $74.0; the TTM figure through Dec 2025 stood at $6.0 (down 99.97% YoY), while the FY2025 annual figure was $6.0, down 99.97% from the prior year.
- Share-based Compensation came in at $74.0 for Q4 2025 at Bluejay Diagnostics, down from $183.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $219589.0 in Q1 2023 to a low of -$42482.0 in Q3 2023.
- A 5-year average of $35540.4 and a median of $5401.0 in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation jumped 76781.71% in 2022 and sank 137.52% in 2023, its largest moves.
- Bluejay Diagnostics' Share-based Compensation stood at $21635.0 in 2021, then jumped by 304.83% to $87586.0 in 2022, then sank by 117.77% to -$15565.0 in 2023, then jumped by 83.41% to -$2582.0 in 2024, then soared by 102.87% to $74.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $74.0, $183.0, and -$1563.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Bluejay Diagnostics | 572,394.44 | -3.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.00 |
| Dec 31, 2025 | 74.00 |
| Sep 30, 2025 | 183.00 |
| Sep 30, 2025 | 183.00 |
| Jun 30, 2025 | -1,563.00 |
| Jun 30, 2025 | -1,563.00 |
| Mar 31, 2025 | 1,312.00 |
| Mar 31, 2025 | 1,312.00 |
| Dec 31, 2024 | -2,582.00 |
| Dec 31, 2024 | -2,582.00 |
| Sep 30, 2024 | 4,792.00 |
| Sep 30, 2024 | 4,792.00 |
| Jun 30, 2024 | 6,010.00 |
| Jun 30, 2024 | 6,010.00 |
| Mar 31, 2024 | 11,874.00 |
| Mar 31, 2024 | 11,874.00 |
| Dec 31, 2023 | -15,565.00 |
| Dec 31, 2023 | -15,565.00 |
| Sep 30, 2023 | -42,482.00 |
| Sep 30, 2023 | -42,482.00 |
| Jun 30, 2023 | 27,702.00 |
| Jun 30, 2023 | 27,702.00 |
| Mar 31, 2023 | 219,589.00 |
| Mar 31, 2023 | 219,589.00 |
| Dec 31, 2022 | 87,586.00 |
| Dec 31, 2022 | 87,586.00 |
| Sep 30, 2022 | 113,219.00 |
| Sep 30, 2022 | 113,219.00 |
| Jun 30, 2022 | 106,114.00 |
| Jun 30, 2022 | 106,114.00 |
| Mar 31, 2022 | 126,086.00 |
| Mar 31, 2022 | 126,086.00 |
| Dec 31, 2021 | 21,635.00 |
| Dec 31, 2021 | 21,635.00 |
| Sep 30, 2021 | 46,504.00 |
| Sep 30, 2021 | 46,504.00 |
| Jun 30, 2021 | 155.00 |
| Jun 30, 2021 | 155.00 |
| Mar 31, 2021 | 164.00 |
| Mar 31, 2021 | 164.00 |
| Dec 31, 2020 | 2,960.00 |
| Dec 31, 2020 | 2,960.00 |
| Sep 30, 2020 | 6,251.00 |
| Sep 30, 2020 | 6,251.00 |